AstraZeneca Pharma India Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
AstraZeneca Pharma India Limited
Symbol
ASTRAZEN
Quarter Ended
31-Mar-2026
Submission
Revision
Revision Remarks
Yes, as we have updated the SRC Committee meeting composition and number of committee meetings.

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Not Applicable
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Not Applicable
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
20-May-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
www.astrazeneca.in
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
www.astrazeneca.in
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
www.astrazeneca.in
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
www.astrazeneca.in
Disclosure Web Link Of Company At Which Details Of Business Is Placed
www.astrazeneca.in
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
www.astrazeneca.in
Disclosure Web Link Of Company At Which Financial Results Is Placed
www.astrazeneca.in
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
www.astrazeneca.in
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
www.astrazeneca.in
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
www.astrazeneca.in
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
www.astrazeneca.in
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
www.astrazeneca.in
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
www.astrazeneca.in
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
www.astrazeneca.in
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
www.astrazeneca.in
Disclosure Web Link Of Secretarial Compliance Report Is Placed
www.astrazeneca.in
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Not Applicable
Fees Or Compensation
Not Applicable
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE203A01020
Market Capitalisation As Per Immediate Previous Financial Year
Top 500 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Tanya Sanish
Name Of Signatory Affirmations
Tanya Sanish
Name Of Signatory For Annual Affirmations
Tayna Sanish
Name Of Signatory For Quartely Affirmations
Tanya Sanish
Name Of The Company
ASTRAZENECA PHARMA INDIA LIMITED
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Not Applicable
Place
Mumbai
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Not Applicable
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
The Company has not provided loans, granted guarantees, comfort letters, securities.
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
A00366
Scrip Code
506820
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Not Applicable
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
ASTRAZEN
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Not Applicable
Type Of Company
Equity
Type Of Submission
Revision
Vacancies In Respect Key Managerial Personnel
Not Applicable
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit7
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Date of BirthDisqualifiedStatusSpecial ResolutionInitial AppointmentRe-appointmentCessationTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MsSHILPA DIVEKAR NIRULA******06619353Non-Executive - Independent DirectorChairperson30-Nov-1973NoActiveNot Applicable29-Dec-202129-Dec-202151.023330
2MsREVATHY ASHOK******00057539Non-Executive - Independent DirectorNot Applicable16-Jan-1959NoActiveNot Applicable02-Dec-201609-Aug-2021111.295553
3MsMONICA WIDHANI******07674403Non-Executive - Independent DirectorNot Applicable18-Jan-1959NoActiveNot Applicable25-Sep-202425-Sep-202418.164463
4MrPRAVEEN RAO AKKINEPALLY******11137771Executive DirectorNot Applicable29-Aug-1974NoActiveNot Applicable01-Jul-20251010
5MrJESUS JAVIER DIAZ-ROPERO ESTESO******10835384Non-Executive - Non Independent DirectorNot Applicable05-Feb-1972NoActiveNot Applicable13-Nov-202419-Mar-20261000
6MsSYLVIA LORENA VARELA RAMON******10410837Non-Executive - Non Independent DirectorNot Applicable20-Mar-1966NoActiveNot Applicable21-Dec-202328-Feb-20261011
7MsHOOI BIEN CHUAH******10381891Non-Executive - Non Independent DirectorNot Applicable17-Jan-1975NoActiveNot Applicable09-Nov-20231010
8MsBHAVANA AGRAWAL******10485441Executive DirectorNot Applicable04-Nov-1978NoActiveNot Applicable08-Feb-20241010

Committee Disclosures

Entry CompComit122
Date of Appointment
08-Feb-2024
Entry CompComit123
Date of Appointment
02-Feb-2017
Entry CompComit124
Date of Appointment
01-Jul-2025
Entry CompComit14
Date of Appointment
25-Sep-2024
Entry CompComit15
Date of Appointment
08-Feb-2022
Entry CompComit16
Date of Appointment
30-May-2025
Entry CompComit17
Date of Appointment
08-Feb-2024
Entry CompComit41
Date of Appointment
08-Feb-2022
Entry CompComit42
Date of Appointment
25-Sep-2024
Entry CompComit43
Date of Appointment
27-May-2024
Date Of Cessation Of Director In Committee
28-Feb-2026
Entry CompComit44
Date of Appointment
01-Mar-2026
Date Of Cessation Of Director In Committee
19-Mar-2026
Entry CompComit45
Date of Appointment
11-Mar-2026
Entry CompComit68
Date of Appointment
08-Feb-2024
Date Of Cessation Of Director In Committee
28-Feb-2026
Entry CompComit69
Date of Appointment
01-Mar-2026
Date Of Cessation Of Director In Committee
19-Mar-2026
Entry CompComit70
Date of Appointment
30-May-2025
Entry CompComit71
Date of Appointment
01-Jul-2025
Entry CompComit72
Date of Appointment
08-Feb-2024
Entry CompComit95
Date of Appointment
25-Sep-2024
Entry CompComit96
Date of Appointment
01-Jul-2025
Entry CompComit97
Date of Appointment
08-Feb-2024
Entry CompComit98
Date of Appointment
08-Aug-2024
Entry CompComit99
Date of Appointment
03-Aug-2020
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
www.astrazeneca.in
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
No

Audit Committee

Additional Position
Chairperson
Director DIN
07674403
Member Name
MONICA WIDHANI
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
06619353
Member Name
SHILPA DIVEKAR NIRULA
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
00057539
Member Name
REVATHY ASHOK
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
10381891
Member Name
HOOI BIEN CHUAH
Position
Non-Executive - Non Independent Director

Audit Committee

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
10381891
Member Name
HOOI BIEN CHUAH
Position
Non-Executive - Non Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00057539
Member Name
REVATHY ASHOK
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
11137771
Member Name
PRAVEEN RAO AKKINEPALLY
Position
Executive Director

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
00057539
Member Name
REVATHY ASHOK
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
06619353
Member Name
SHILPA DIVEKAR NIRULA
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
10410837
Member Name
SYLVIA LORENA VARELA RAMON
Position
Non-Executive - Non Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
10835384
Member Name
JESUS JAVIER DIAZ-ROPERO ESTESO
Position
Non-Executive - Non Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
07674403
Member Name
MONICA WIDHANI
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Nomination and remuneration committee

Risk Management Committee

Additional Position
Chairperson
Director DIN
07674403
Member Name
MONICA WIDHANI
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
11137771
Member Name
PRAVEEN RAO AKKINEPALLY
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
10485441
Member Name
BHAVANA AGRAWAL
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
99999999
Member Name
SRIKANTH B S
Notes
Mr. Srikanth B.S. is not a Director, hence DIN is not available.
Position
Site Lead - India Operations

Risk Management Committee

Additional Position
Member
Director DIN
99999999
Member Name
AMARPREET KAUR AHUJA
Notes
Ms. Amarpreet Kaur Ahuja is not a Director, hence DIN is not available.
Position
Country HR Director

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
10410837
Member Name
SYLVIA LORENA VARELA RAMON
Notes
Please note that Ms. Sylvia Varela served as Chairperson of the Stakeholders Relationship Committee until February 28, 2026.
Position
Non-Executive - Non Independent Director

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
10835384
Member Name
JESUS JAVIER DIAZ-ROPERO ESTESO
Notes
Please note that Mr. Jesus Javier Diaz Ropero Esteso served as Chairperson of the Stakeholders Relationship Committee until March 19, 2026. Accordingly, as of March 31, 2026, the Committee did not have a Chairperson and the vacancy will be filled within the stipulated timeline shortly in due course.
Position
Non-Executive - Non Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
06619353
Member Name
SHILPA DIVEKAR NIRULA
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
11137771
Member Name
PRAVEEN RAO AKKINEPALLY
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
10485441
Member Name
BHAVANA AGRAWAL
Position
Executive Director

Stakeholders Relationship Committee

Entry D_MeetingComit7
Disclosure Of Meeting Of Committee Notes In Absence Of Date Text Block
Filing this as a part of revised disclosure.
Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
07-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD2
Dates Of Meeting If Any In The Relevant Quarter
11-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
95
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD3
Dates Of Meeting If Any In The Relevant Quarter
11-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
27
Number Of Directors Present In Meeting Of Board Of Directors
5
Number Of Independent Directors Attending The Meeting
2
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
07-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
95
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
27
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
2
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Previous Quarter
07-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
95
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
2
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit7
Dates Of Meeting Of The Committee In The Relevant Quarter
11-Mar-2026
Maximum Gap Between Any Two Consecutive Meetings
27
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
4
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
www.astrazeneca.in
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
www.astrazeneca.in
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
0
No Of Investor Complaints During The Period
1
No Of Investor Complaints Received During The Period
1
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
1
Entry PY_I
No Of Investor Complaints
0
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Not Applicable
Reason For Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Not Applicable To The Entity
Disclosure related to acquisition of shares or voting rights in unlisted companies is not applicable to the Company in the reporting quarter.
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
No
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
The Company has challenged the matter before the Income-tax Appellate Tribunal (ITAT) by filing an appeal.
Date of Initiation
01-Jun-2023
Opposing Party
Assessment Unit, Income tax department
Status (Previous Disclosure)
Company has received a final assessment order from the Assessment Unit being passed under section 143(3) read with section 144C(13) and 144(B) of the Income Tax Act, 1961 for assessment year 2022-23, wherein adjustment on the legacy transfer pricing and corporate tax issues have been proposed. The matter will be challenged before the Income-tax Appellate Tribunal (ITAT) by filing an appeal.
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
Disclosure related to imposition of fine or penalty is not applicable to the Company in the reporting quarter.
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No